But we need systemic change to make that happen. For now, patients and advocates alike are watching Congress closely, hoping that the growing scrutiny on pharmaceutical pricing will lead to real reformsand that the next time senators ask why GLP-1s are so much cheaper abroad, there will be a better answer.
For participants without diabetes at baseline, the research demonstrated preventive effects on glucose metabolism
The loss of triglycerides causes the VLDL to transition to an LDL
Swelling and thickening of the tendon
Constructing lactylation-related genes prognostic model to effectively predict the disease-free survival and treatment responsiveness in prostate cancer based on machine learning
Aftercare does not determine every complication Technique, anatomy, product placement, dose, and underlying health often matter more than minor everyday movement